RECENT POSTS
- Your First Move For Friday July 10th
- Web Extra: Real Estate Reality
- Fast Money After Dark: Casino Stocks
- Your Questions About Blackstone & Citigroup
- Mischief Makers Attempt To Thwart World's Computers
- Pops & Drops: Netflix, Western Union...
- Don’t Get Burned By Hot Emerging Markets
- Betting On Biotech Blockbusters
FAST MONEY FEATURES
FAST MONEY POLLGet in the post game. Respond to our "Question of the Day" right now.
TRADE SCHOOLGrab a pencil because school is in session and the Fast Money traders are teaching class.
FAST MONEY PODCASTSDownload Fast Money onto your MP3 Player.
FAST MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
SHOP FOR FAST MONEY MERCHANDISEGet your game on with Fast Money gear.
FAST MONEY PHOTOS!Check out our scrapbook. These "pix" are guaranteed winners.
NEWSLETTERSign up and receive a recap email every Friday after the show!
FAST MONEY MOBILE ALERTSGet advanced information about the next Fast Money.
Text Size 
 |
CNBC’s Mike Huckman said Pfizer’s “bombshell” announcement that it will cease selling its once-promising inhalable insulin product Exubera took down a number of stocks in the diabetes care industry, including Lilly, Alkermes (ALKS), MannKind (MNKD) and Nektar (NKTR). The latter – Pfizer’s partner in Exubera – plunged 17% on the news, Huckman reported.
Going forward, analysts expect Merck to see growth from its HPV vaccine but Schering-Plough could be the big story, said Huckman. According to a Deutsche Bank analyst, SGP is the most-levered of all the drug companies to international growth and appers poised to benefit from the weak dollar when it reports Monday.
Jeff Macke is bullish on the entire drug complex. He proposed that biotech and pharma companies team up. Pharma has plenty of cash but no pipeline; biotech has the pipeline but no cash, he said, calling it a “match made in heaven.”
To that end, Karen Finerman hopes Merck puts a bid in for Biogen (BIIB).
______________________________________________________
Got something to say? Send us an e-mail at and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to .
Trader disclosure: On Oct 18, 2007, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (INTC); Najarian Owns ( C), (GOOG)(CY); Najarian Owns (SNDK) Options; Finerman Owns (C), (GS); Finerman's Firm And Finerman Own (ASD), (KALU); Finerman's Firm Owns (NYX), (MSFT), (LTD), (BIIB), (BEAS), (COP), (TGT), (VMSI), (WMT); Finerman's Firm Owns S&P 500 Index Puts; Finerman's Firm Owns Russell 2000 Index Puts
Data is a real-time snapshot *Data is delayed at least 15 minutes